To Compare Efficacy of Low Dose Diclofenac (25mg) in Management of Postoperative Pain After Periodontal Flap Surgery

• Status: Completed
• Trial end date: 2017-05-21
• Target enrollment: 0
• Participant gender: All

Summary

Pain after periodontal surgical procedures is a common manifestation. The perception of pain is highly subjective and varies substantially among individuals. Many factors affect pain perception, such as the nature, duration, and extent of the surgery and psychological aspects (e.g., stress and anxiety). Pain after periodontal surgery is an example of acute dental pain of mild to moderate severity. Non-steroidal anti-inflammatory drugs (NSAIDs) have a significant advantage in the control of pain after periodontal or oral surgical procedures.

Diclofenac is a powerful anti-inflammatory and analgesic drug that is well suited for local use in the oral cavity. Diclofenac competes with arachidonic acid in a dose dependent manner for binding with platelet COX. This results in decreased production of PG and thus reduces inflammation, swelling and pain.

As Diclofenac associated with many adverse effects, like gastric irritability, nausea, headache, dizziness. Undesirable effects may be minimized by using the lowest effective dose for the shortest duration necessary to control symptoms. As many of clinical trials have suggested Diclofeanc 50 mg alleviates the postoperative pain. So main aim of the study was to evaluate the effectiveness of low dose Diclofenac(25mg) in reducing the post operative pain after periodontal flap surgeries. Thus comparing the effects of low dose Diclofenac and Diclofenac 50mg for reducing post-operative pain.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Tatyasaheb Kore Dental College
• Treatments: Diclofenac

Criteria

Inclusion Criteria:

1. Generalized moderate/severe chronic periodontitis

2. The probing depth (PD) of the surgical sites in the both group ranged from 5 to 8 mm.

3. The clinical attachment level (CAL) at the surgical sites in both the group ranged from 5 to 9 mm.

4. Quadrant with the presence of atleast 6 teeth will be selected for study.

Exclusion Criteria:

1. Tobacco in any form and alcoholics.

2. Pregnant and lactating mother.

3. Patients with history of systemic ailments, patients under ant-inflammatory/antibiotic 3 months prior to recruitment for study.

4. Subjects who had received periodontal treatment within the previous 6 months.

5. Patient who have history of intolerance or hypersensitivity to Diclofenac and with gastric diseases